Bigul

VISTA PHARMACEUTICALS LTD. - 524711 - Board Meeting Intimation for Approval Un Audited Financial Results For The Quarter Ended 31.12.2023

VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024 ,inter alia, to consider and approve 1. Un-Audited financial results for the quarter ended 31.12.2023 2. Limited Review Report for quarter ended 31.12.2023 3. Any other business with the permission of the Chair.
02-02-2024
Bigul

VISTA PHARMACEUTICALS LTD. - 524711 - Announcement under Regulation 30 (LODR)-Allotment

Kindly note the allotment of 2,66,667 equity shares pursuant to the conversion of 2,66,667 warrants issued to others on a private placement
08-01-2024
Bigul

VISTA PHARMACEUTICALS LTD. - 524711 - Closure of Trading Window

Intimation of closure of Trading window from 01st January 2024 till 48 hours from the conclusion of the Board Meeting in which the financial result for the quarter ended 31st December 2023 will be approved
30-12-2023
Bigul

VISTA PHARMACEUTICALS LTD. - 524711 - Announcement under Regulation 30 (LODR)-Allotment

Kindly note the allotment of 5,33,333 equity shares pursuant to the conversion of 5,33,333 warrants issued to others on a private placement
30-12-2023
Bigul

VISTA PHARMACEUTICALS LTD. - 524711 - Announcement under Regulation 30 (LODR)-Allotment

Kindly note the allotment of 2,00,000 equity shares pursuant to the conversion of 2,00,000 warrants issued to others on a private placement
06-12-2023
Next Page
Close

Let's Open Free Demat Account